Director, Regulatory Affairs Seattle, Washington, United States; South San Francisco, California, Un

Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response. We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell's product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency. This role can be remote with regular travel to either our Seattle, WA or South San Francisco, CA offices. The Director of Regulatory Affairs/Global Regulatory Lead (GRL) will be focusing on the development of cutting-edge CAR-T cell therapies in oncology. As the GRL, you will define, develop, and execute the global regulatory strategy for assigned CAR-T programs from early clinical development through licensure (BLA/MAA) and lifecycle management. You will serve as the primary regulatory representative to global health authorities (FDA, EMA, etc.), ensuring alignment with business objectives and driving innovative approaches to accelerate the development of transformative therapies for patients.

KEY ROLE AND RESPONSIBILITIES:

Global Regulatory Strategy & Leadership Develop & Execute Strategy: Create and lead comprehensive, creative, and innovative global regulatory strategies to support the development and commercialization of CAR-T cell therapy products. Represent Regulatory: Represent the Regulatory Team in cross-functional meetings, ensuring alignment with regional regulatory requirements, CMC, and clinical development plans. Risk Mitigation: Proactively identify regulatory risks, develop contingency plans, and anticipate hurdles in the evolving CAR-T regulatory landscape. Drive Milestones: Accountable for timely submission and approval of global regulatory dossiers (IND, CTA, BLA, MAA). Health Authority Interactions Primary Liaison: Act as the primary point of contact and lead negotiations with regulatory agencies (FDA, EMA, etc.), including managing FDA meetings (Pre-IND, EOP2, Pre-BLA) and briefing document preparation. Agency Negotiation: Support regional teams in resolving key regulatory issues to expedite clinical study country expansion. Cross-Functional Collaboration Strategic Input: Partner with CMC, Clinical Development, Translational Medicine, and Medical Affairs teams to align regulatory strategy with scientific breakthroughs and market access goals. Content Review: Review and approve key regulatory documents, including clinical protocols, investigator brochures, and non-clinical reports. Mentor Staff: Provide coaching and mentoring to junior regulatory staff and other RA team members. Stay Current: Monitor and analyze emerging regulations, guidelines, and competitor intelligence in the cell and gene therapy field.

PREFERRED EDUCATION:

Bachelor's degree in Life Sciences required. Advanced degree (PhD, PharmD, or MD) is strongly preferred.

PREFERRED EXPERIENCE:

Experience: A minimum of 15+ years in the biopharmaceutical industry, with at least 8 years of direct Regulatory Affairs experience. Modalities: Substantial experience in cell and gene therapy, specifically with CAR-T or T-cell engaging modalities. Submissions: Proven track record of leading major submissions (IND/CTA) and experience in BLA/MAA preparation. HA Interactions: Proven ability to interact effectively and negotiate with regulatory authorities. Desired Skills: Deep understanding of FDA regulations for Advanced Therapy Medicinal Products (ATMPs). Strong strategic thinking and ability to balance short-term needs with long-term vision. Exceptional communication and negotiation skills. Proven ability to work in a complex, matrixed, and fast-paced environment The salary range for this position is $210,000 to $260,000, annually, with the opportunity to earn an annual bonus. The salary range is an estimate, and the actual salary may vary based on Lyell’s compensation practices and an applicant’s qualifications and experience. Employees are also eligible to participate in Lyell's Equity Incentive Plan. At Lyell, we believe that highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse and inclusive culture for all employees. Lyell is proud to be an equal opportunity employer and does not discriminate on the basis of race, color, citizenship status, national origin, ancestry, sex, sexual orientation, age, religion, creed, physical or mental disability, medical condition, marital status, veteran status or any other characteristics protected under applicable federal, state and local laws. A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability. A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service. An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval, or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense. An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval, or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985. #J-18808-Ljbffr Lyell